Mechanistic studies of the anti-AML activity of atovaquone revealed that it induced the ISR, with increased phosphorylation of eIF2α and ATF4 protein levels while also increasing mRNA levels of numerous pro-apoptotic ATF4 target genes, including CHOP [79]. The gene discussed is EIF2A; the disease is acute myeloid leukemia.